Apollomics Class A Stock Analysis
| APLM Stock | 18.81 0.21 1.13% |
IPO Date 26th of November 2021 | 200 Day MA 9.1432 | 50 Day MA 17.0897 | Beta 1.811 |
At this time, Apollomics' Net Debt To EBITDA is very stable compared to the past year. As of the 6th of February 2026, Debt To Equity is likely to grow to 0.19, though Net Debt is likely to grow to (7.5 M). Apollomics' financial risk is the risk to Apollomics stockholders that is caused by an increase in debt.
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.0848 | Current Value 0.0806 | Quarterly Volatility 0.84079681 |
Apollomics Class A is overvalued with Real Value of 10.34 and Target Price of 2.0. The main objective of Apollomics stock analysis is to determine its intrinsic value, which is an estimate of what Apollomics Class A is worth, separate from its market price. There are two main types of Apollomics' stock analysis: fundamental analysis and technical analysis.
The Apollomics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Apollomics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Apollomics Stock trading window is adjusted to America/New York timezone.
Apollomics | Build AI portfolio with Apollomics Stock |
Apollomics Stock Analysis Notes
The company recorded a loss per share of 52.8. Apollomics Class A had not issued any dividends in recent years. The entity had 1:100 split on the 25th of November 2024. For more info on Apollomics Class A please contact HungWen Chen at 650 209 4055 or go to https://www.apollomicsinc.com.Apollomics Class A Investment Alerts
| Apollomics Class A is way too risky over 90 days horizon | |
| Apollomics Class A appears to be risky and price may revert if volatility continues | |
| Apollomics Class A has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 198 K. Net Loss for the year was (53.86 M) with profit before overhead, payroll, taxes, and interest of 198 K. | |
| Apollomics generates negative cash flow from operations | |
| Apollomics Class A has a poor financial position based on the latest SEC disclosures | |
| Latest headline from thelincolnianonline.com: Apollomics Upgraded at Wall Street Zen |
Apollomics Largest EPS Surprises
Earnings surprises can significantly impact Apollomics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-04-03 | 2025-03-31 | -0.15 | -16.92 | -16.77 | 11180 |
Apollomics Environmental, Social, and Governance (ESG) Scores
Apollomics' ESG score is a quantitative measure that evaluates Apollomics' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Apollomics' operations that may have significant financial implications and affect Apollomics' stock price as well as guide investors towards more socially responsible investments.
Apollomics Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 44.92 M.Apollomics Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (5.45) | (5.18) | |
| Return On Capital Employed | (8.50) | (8.08) | |
| Return On Assets | (4.73) | (4.49) | |
| Return On Equity | (12.73) | (12.10) |
Management Efficiency
Apollomics Class A has return on total asset (ROA) of (0.7507) % which means that it has lost $0.7507 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.3367) %, meaning that it created substantial loss on money invested by shareholders. Apollomics' management efficiency ratios could be used to measure how well Apollomics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 6th of February 2026, Return On Tangible Assets is likely to grow to -5.18. In addition to that, Return On Capital Employed is likely to grow to -8.08. As of the 6th of February 2026, Total Assets is likely to drop to about 11.2 M. In addition to that, Non Current Assets Total is likely to drop to about 2.4 M| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.73 | 4.96 | |
| Tangible Book Value Per Share | 3.04 | 3.19 | |
| Enterprise Value Over EBITDA | (0.01) | (0.01) | |
| Price Book Value Ratio | 1.67 | 1.75 | |
| Enterprise Value Multiple | (0.01) | (0.01) | |
| Price Fair Value | 1.67 | 1.75 | |
| Enterprise Value | 209.8 K | 186.5 K |
The decision-making processes within Apollomics are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Technical Drivers
As of the 6th of February, Apollomics shows the Mean Deviation of 6.17, downside deviation of 7.07, and Risk Adjusted Performance of 0.0786. Apollomics Class A technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Apollomics Class A coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Apollomics Class A is priced correctly, providing market reflects its regular price of 18.81 per share. Given that Apollomics has jensen alpha of 0.7134, we suggest you to validate Apollomics Class A's prevailing market performance to make sure the company can sustain itself at a future point.Apollomics Class A Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Moving Average is predictive technique used to analyze Apollomics Class A price data points by creating a series of averages of different subsets of Apollomics entire price series.
Apollomics Class A Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Apollomics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Apollomics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Apollomics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Yungfong Song over a year ago Conversion by Yungfong Song of 2482500 shares of Apollomics |
Apollomics Outstanding Bonds
Apollomics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Apollomics Class A uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Apollomics bonds can be classified according to their maturity, which is the date when Apollomics Class A has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Apollomics Predictive Daily Indicators
Apollomics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Apollomics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Apollomics Corporate Filings
| 2nd of February 2026 Other Reports | ViewVerify | |
6K | 22nd of December 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 12th of December 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 19th of November 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 18th of November 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 21st of October 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 16th of October 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 14th of October 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
Apollomics Forecast Models
Apollomics' time-series forecasting models are one of many Apollomics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Apollomics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Apollomics Bond Ratings
Apollomics Class A financial ratings play a critical role in determining how much Apollomics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Apollomics' borrowing costs.| Piotroski F Score | 4 | Poor | View |
| Beneish M Score | (10.94) | Unlikely Manipulator | View |
Apollomics Total Assets Over Time
Apollomics Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Apollomics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Apollomics Debt Ratio | 8.06 |
Apollomics Corporate Bonds Issued
Apollomics Short Long Term Debt Total
Short Long Term Debt Total |
|
About Apollomics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Apollomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Apollomics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Apollomics. By using and applying Apollomics Stock analysis, traders can create a robust methodology for identifying Apollomics entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (311.31) | (326.87) | |
| Operating Profit Margin | (191.53) | (201.10) | |
| Net Loss | (244.81) | (257.05) |
Current Apollomics Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Apollomics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Apollomics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 2.0 | Buy | 1 | Odds |
Most Apollomics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Apollomics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Apollomics Class A, talking to its executives and customers, or listening to Apollomics conference calls.
Apollomics Stock Analysis Indicators
Apollomics Class A stock analysis indicators help investors evaluate how Apollomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Apollomics shares will generate the highest return on investment. By understating and applying Apollomics stock analysis, traders can identify Apollomics position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 32.1 M | |
| Common Stock Shares Outstanding | 926.5 K | |
| Total Stockholder Equity | 4.9 M | |
| Total Cashflows From Investing Activities | 6 M | |
| Tax Provision | 259 K | |
| Property Plant And Equipment Net | 1 M | |
| Cash And Short Term Investments | 9.8 M | |
| Cash | 9.8 M | |
| Net Debt | -8.8 M | |
| 50 Day M A | 17.0897 | |
| Total Current Liabilities | 7.4 M | |
| Other Operating Expenses | 42.3 M | |
| Non Current Assets Total | 2.8 M | |
| Non Currrent Assets Other | 75 K | |
| Stock Based Compensation | 10.9 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apollomics Class A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Will Biotechnology sector continue expanding? Could Apollomics diversify its offerings? Factors like these will boost the valuation of Apollomics. If investors know Apollomics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Apollomics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (52.80) | Revenue Per Share | Quarterly Revenue Growth 2.623 | Return On Assets | Return On Equity |
The market value of Apollomics Class A is measured differently than its book value, which is the value of Apollomics that is recorded on the company's balance sheet. Investors also form their own opinion of Apollomics' value that differs from its market value or its book value, called intrinsic value, which is Apollomics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Apollomics' market value can be influenced by many factors that don't directly affect Apollomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Apollomics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Apollomics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Apollomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.